Diabetes Care 45(12):30753090
Biol Pharm Bull 31:11691176 Acknowledgements The authors appreciate the effort of laboratory assistants and the laboratory in which the work was done
A 30-month, randomized, placebo-controlled trial of coenzyme Q 10 (600 mg/day), remacemide, or both in 347 patients with early Huntington's disease found that neither coenzyme Q 10 nor remacemide significantly altered the decline in total functional capacity, although coenzyme Q 10 supplementation (with or without remacemide) resulted in a nonsignificant trend toward a slower decline (73)
Periventricular leukomalacia (PVL) is associated with oligodendrocyte damage
The drug also causes food to linger in the stomach, which prolongs the feeling of fullness
Each lot is US-compounded and verified by HPLC and LC-MS to at least 99% purity, with a certificate of analysis provided per lot